Results

Total Results: 396 records

Showing results for "obese".

81. Transparency of Reporting Requirements: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Management of Infertility Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Management of Infer tility …

82. Management and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
    May 01, 2016 - tends to be slightly more common in women and is more common among individuals who are overweight or obese

83. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/effect-dietary-digestible/research

84. Executive Summary: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-research-executive-summ.pdf
    March 01, 2025 - Executive Summary: Breastfeeding and Health Outcomes for Infants and Children Systematic Review Breastfeeding and Health Outcomes for Infants and Children Executive Summary Main Points Background and Purpose While it is widely accepted that breastfeeding and the consumption of human milk is…

85. Disposition of Comments for CER 160 Binge Eating Disorder (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
    December 09, 2015 - Virtually all of the patients in the BED trials were overweight or obese and so weight reduction was … were associated with weight reduction in study populations that were virtually all overweight or obese … Dieting and the development of eating disorders in overweight and obese adults. … 10.1002/1098-108X(199204)11:3<191::AID- EAT2260110302>3.0.CO;2-S In addition, the high rates in obese … feel it is important contextually to include mention of higher estimates of BED prevalence among obese

86. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - $2,600 per patient per year) overall, even if used by only 1 percent (1 million) of the overweight and obese … offset by improved weight control and reduction in health costs associated with being overweight or obese … use in conjunction with diet, exercise, and behavior modifications in patients who are overweight or obese … activity for chronic weight management in adult patients with an initial BMI of 30 kg/m2 or more (obese

87. Tonsillectomy Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
    February 10, 2016 - subgroups  such  as  very  young  children  (1-­2  years  old)  and   children  who  are  overweight  or  obese … In  children  with  OSDB  who  are  overweight  or  obese,  what  is  the  comparative  effectiveness … stay         1d   Children  (3-­18   years  of  age)   with  OSDB   who  are   overweight  or   obese

88. Weight Control | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/weight-control

89. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening for and Management of Chronic Kidney Disease Stages 1-3 I. Background and Objectives for the Systematic Review T…

90. A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
    April 20, 2022 - A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features Evidence-based Practice Center Systematic Review Protocol Project Title: A Systematic Review of Postpa…

91. Medical Care for Adults with Down Syndrome (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
    July 09, 2024 - exp obesity/ or overweight/ or weight gain/ or ("body mass index" or BMI or "nutritional status" or obese

92. Medical Care for Adults with Down Syndrome (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - exp obesity/ or overweight/ or weight gain/ or ("body mass index" or BMI or "nutritional status" or obese

93. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
    December 20, 2017 - FeNO is usually low in obese patients and although this is mentioned in a line statement, nothing was … how this can affect use of FeNO as a tool to predict exacerbations, use of medications, etc., in the obese … With greater than two-thirds of the US adult population is now either overweight or obese, it seems

94. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults Laurel A. Habel, Ph.D. William O. Cooper, M.D., M.P.H. Colin M. Sox, M.D. M.S. K. Arnold Chan, M.D., Sc.D. Patrick G. Arbogast, Ph.D. T. Craig Cheetham, Pharm.D., M.S. Virginia P. Quinn, Ph.D., M.P.H. Bruce H. Firema…

95. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
    April 08, 2024 - Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review I. Background and Objectives for the Systematic Review This…

96. Nppv-Respiratory-Failure Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
    July 01, 2012 - 1 Comparative Effectiveness Review Number 68 Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure Executive Summary Background Acute respiratory failure is a life- threatening condition characterized by an inability to maintain normal levels of oxygen and/or carbon dioxide gas exc…

97. Urinary-Incontinence-Treatment Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
    October 29, 2012 - Trospium was effective in resolving UI regardless of body mass index in obese and normal weight women … Weight Loss Weight loss and exercise improved UI in obese women without evident harms. … Follow up duration Outcomes and findings Suzanne Phelan, 2012 7 RCT 2739 overweight/obese … Trospium was effective in resolving UI regardless of body mass index in obese and normal weight women … Weight Loss Weight loss and exercise improved UI in obese women without evident harms.

98. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…

99. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - KQ1_IgG Duration_n=3 Observational studies examining IgG Duration Author Year Title PMID Link/URL Country Study Design Length of follow-up (Months) Population category Population Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) years or Median (IQR) Race stratifi…

100. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
     September 13, 2006 - Slide 1 Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals Presented by W. Douglas Evans, Ph.D. Lauren McCormack, Ph.D., M.S.P.H Presented at Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of …